Interference in the shared-Stroop task:a comparison of self- and other-monitoring

Co-actors represent and integrate each other's actions, even when they need not monitor one another. However, monitoring is important for successful interactions, particularly those involving language, and monitoring others' utterances probably relies on similar mechanisms as monitoring one's own. We investigated the effect of monitoring on the integration of self- and other-generated utterances in the shared-Stroop task. In a solo version of the Stroop task (with a single participant responding to all stimuli; Experiment 1), participants named the ink colour of mismatching colour words (incongruent stimuli) more slowly than matching colour words (congruent). In the shared-Stroop task, one participant named the ink colour of words in one colour (e.g. red), while ignoring stimuli in the other colour (e.g. green); the other participant either named the other ink colour or did not respond. Crucially, participants either provided feedback about the correctness of their partner's response (Experiment 3) or did not (Experiment 2). Interference was greater when both participants responded than when they did not, but only when their partners provided feedback. We argue that feedback increased interference because monitoring one's partner enhanced representations of the partner's target utterance, which in turn interfered with self-monitoring of the participant's own utterance

Lexical Alignment to Non-native Speakers

Two picture-matching-game experiments investigated if lexical-referential alignment to non-native speakers is enhanced by a desire to aid communicative success (by saying something the conversation partner can certainly understand), a form of audience design. In Experiment 1, a group of native speakers of British English that was not given evidence of their conversation partners’ picture-matching performance showed more alignment to non-native than to native speakers, while another group that was given such evidence aligned equivalently to the two types of speaker. Experiment 2, conducted with speakers of Castilian Spanish, replicated the greater alignment to non-native than native speakers without feedback. However, Experiment 2 also showed that production of grammatical errors by the confederate produced no additional increase of alignment even though making errors suggests lower communicative competence. We suggest that this pattern is consistent with another collaborative strategy, the desire to model correct usage. Together, these results support a role for audience design in alignment to non-native speakers in structured task-based dialogue, but one that is strategically deployed only when deemed necessary

Do you what I say? People reconstruct the syntax of anomalous utterances

We frequently experience and successfully process anomalous utterances. Here we examine whether people do this by “correcting” syntactic anomalies to yield well-formed representations. In two structural priming experiments, participants’ syntactic choices in picture description were influenced as strongly by previously comprehended anomalous (missing-verb) prime sentences as by well-formed prime sentences. Our results suggest that comprehenders can reconstruct the constituent structure of anomalous utterances – even when such utterances lack a major structural component such as the verb. These results also imply that structural alignment in dialogue is unaffected if one interlocutor produces anomalous utterances.We acknowledge Spanish Government grants PSI 2008-01191/PSIC and Consolider Ingenio-2010 CE-CSD2007-00121, and pre-doctoral scholarship FPU-AP2005-4496 (II); Economic and Social Research Council (ESRC) grant RES-062-23-0376; a British Academy/Leverhulme Trust Senior Research Fellowship (HPB); and National Institutes of Health R01 grants HD050287, HD051030, and DC011492

Nonconscious priming of communication

This study investigated whether nonconscious priming can affect the communicative quality of narratives. In two experiments, narrators were primed with words associated with helpfulness or unhelpfulness, and then, in an apparently unrelated task, read and retold a short story to addressees. In Experiment 1, the narrator provided a spoken description, and we also manipulated whether the narrator retold the story to the addressee or to a microphone. In Experiment 2, the narrator provided a written description. In both experiments, narrators primed with helpful words took longer to read the story and provided retellings that were rated to be higher quality than narrators primed with unhelpful words. We propose that priming the concept of helpfulness influences the processes involved in message construction

Shared information structure: Evidence from cross-linguistic priming

This study asked whether bilinguals construct a language-independent level of information structure for the sentences that they produce. It reports an experiment in which a Polish–English bilingual and a confederate of the experimenter took turns to describe pictures to each other and to find those pictures in an array. The confederate produced a Polish active, passive, or conjoined noun phrase, or an active sentence with object–verb–subject order (OVS sentence). The participant responded in English, and tended to produce a passive sentence more often after a passive or an OVS sentence than after a conjoined noun phrase or active sentence. Passives and OVS sentences are syntactically unrelated but share information structure, in that both assign emphasis to the patient. We therefore argued that bilinguals construct a language-independent level of information structure during speech

Lexically-specific syntactic restrictions in second-language speakers

In two structural priming experiments, we investigated the representations of lexically-specific syntactic restrictions of English verbs for highly proficient and immersed second language (L2) speakers of English. We considered the interplay of two possible mechanisms: generalization from the first language (L1) and statistical learning within the L2 (both of abstract structure and of lexically-specific information). In both experiments, L2 speakers with either Germanic or Romance languages as L1 were primed to produce dispreferred double-object structures involving non-alternating dative verbs. Priming occurred from ungrammatical double-object primes involving different non-alternating verbs (Experiment 1) and from grammatical primes involving alternating verbs (Experiment 2), supporting abstract statistical learning within the L2. However, we found no differences between L1-Germanic speakers (who have the double object structure in their L1) and L1-Romance speakers (who do not), inconsistent with the prediction for between-group differences of the L1-generalization account. Additionally, L2 speakers in Experiment 2 showed a lexical boost: There was stronger priming after (dispreferred) non-alternating same-verb double object primes than after (grammatical) alternating different-verb primes. Such lexically-driven persistence was also shown by L1 English speakers (Ivanova et al., 2012a) and may underlie statistical learning of lexically-dependent structural regularities. We conclude that lexically-specific syntactic restrictions in highly proficient and immersed L2 speakers are shaped by statistical learning (both abstract and lexically-specific) within the L2, but not by generalization from the L1

Aspirin and cancer survival: a systematic review and meta-analyses of 118 observational studies of aspirin and 18 cancers.

BackgroundDespite the accumulation of research papers on aspirin and cancer, there is doubt as to whether or not aspirin is an acceptable and effective adjunct treatment of cancer. The results of several randomised trials are awaited, and these should give clear evidence on three common cancers: colon, breast and prostate. The biological effects of aspirin appear likely however to be of relevance to cancer generally, and to metastatic spread, rather than just to one or a few cancers, and there is already a lot of evidence, mainly from observational studies, on the association between aspirin and survival in a wide range of cancers.AimsIn order to test the hypothesis that aspirin taking is associated with an increase in the survival of patients with cancer, we conducted a series of systematic literature searches to identify clinical studies of patients with cancer, some of whom took aspirin after having received a diagnosis of cancer.ResultsThree literature searches identified 118 published observational studies in patients with 18 different cancers. Eighty-one studies report on aspirin and cancer mortality and 63 studies report on all-cause mortality. Within a total of about a quarter of a million patients with cancer who reported taking aspirin, representing 20%-25% of the total cohort, we found aspirin to be associated with a reduction of about 20% in cancer deaths (pooled hazard ratio (HR): 0.79; 95% confidence intervals: 0.73, 0.84 in 70 reports and a pooled odds ratio (OR): 0.67; 0.45, 1.00 in 11 reports) with similar reductions in all-cause mortality (HR: 0.80; 0.74, 0.86 in 56 studies and OR: 0.57; 0.36, 0.89 in seven studies). The relative safety of aspirin taking was examined in the studies and the corresponding author of every paper was written to asking for additional information on bleeding. As expected, the frequency of bleeding increased in the patients taking aspirin, but fatal bleeding was rare and no author reported a significant excess in fatal bleeds associated with aspirin. No author mentioned cerebral bleeding in the patients they had followed.ConclusionsThere is a considerable body of evidence suggestive of about a 20% reduction in mortality in patients with cancer who take aspirin, and the benefit appears not to be restricted to one or a few cancers. Aspirin, therefore, appears to deserve serious consideration as an adjuvant treatment of cancer, and patients with cancer, and their carers, have a right to be informed of the available evidence

Linguistic alignment between people and computers

There is strong evidence that when two people talk to each other, they tend to converge, or align, on common ways of speaking (e.g., Pickering and Garrod, 2004). In this paper, we discuss possible mechanisms that might lead to linguistic alignment, contrasting mechanisms that are encapsulated within the language processing system, and so unmediated by beliefs about the interlocutor, with mechanisms that are mediated by beliefs about the interlocutor and that are concerned with considerations of either communicative success or social affect. We consider how these mechanisms might be implicated in human–computer interaction (HCI), and then review recent empirical studies that investigated linguistic alignment in HCI. We argue that there is strong evidence that alignment occurs in HCI, but that it differs in important ways from that found in interactions between humans: It is generally stronger and has a larger mediated component that is concerned with enhancing communicative success

Aspirin and cancer: biological mechanisms and clinical outcomes

Evidence on aspirin and cancer comes from two main sources: (1) the effect of aspirin upon biological mechanisms in cancer, and (2) clinical studies of patients with cancer, some of whom take aspirin. A series of systematic literature searches identified published reports relevant to these two sources. The effects of aspirin upon biological mechanisms involved in cancer initiation and growth appear to generate reasonable expectations of effects upon the progress and mortality of cancer. Clinical evidence on aspirin appears overall to be favourable to the use of aspirin, but evidence from randomized trials is limited, and inconsistent. The main body of evidence comes from meta-analyses of observational studies of patients with a wide range of cancers, about 25% of whom were taking aspirin. Heterogeneity is large but, overall, aspirin is associated with increases in survival and reductions in metastatic spread and vascular complications of different cancers. It is important that evaluations of aspirin used as an adjunct cancer treatment are based upon all the available relevant evidence, and there appears to be a marked harmony between the effects of aspirin upon biological mechanisms and upon the clinical progress of cancer